180 Life Sciences Secures $425 Million for Ethereum-Focused Investments

The biotechnology company 180 Life Sciences (NASDAQ: ATNF) announced a successful private placement raising $425 million, fueling its expansion into an Ethereum treasury strategy. The financing round, spearheaded by Electric Capital and Harbour Island, was supported by leading cryptocurrency investment firms like Borderless Capital and Polychain Capital. This move suggests a strategic shift towards incorporating blockchain technology, specifically Ethereum, in their operations.